相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The apparently very variable potency of the anti-depressant fluoxetine
J. P. Sumpter et al.
AQUATIC TOXICOLOGY (2014)
An integrated approach for prioritizing pharmaceuticals found in the environment for risk assessmerit, monitoring and advanced research
Daniel J. Caldwell et al.
CHEMOSPHERE (2014)
In Silico Analysis of the Conservation of Human Toxicity and Endocrine Disruption Targets in Aquatic Species
Fiona M. McRobb et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2014)
Mode of action of human pharmaceuticals in fish: The effects of the 5-alpha-reductase inhibitor, dutasteride, on reproduction as a case study
Luigi Margiotta-Casaluci et al.
AQUATIC TOXICOLOGY (2013)
Behavioral and neurogenomic transcriptome changes in wild-derived zebrafish with fluoxetine treatment
Ryan Y. Wong et al.
BMC GENOMICS (2013)
The Read-Across Hypothesis and Environmental Risk Assessment of Pharmaceuticals
Mariann Rand-Weaver et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2013)
A list of fish species that are potentially exposed to pesticides in edge-of-field water bodies in the European Union-a first step towards identifying vulnerable representatives for risk assessment
Lara Ibrahim et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2013)
iPhone® applications as versatile video tracking tools to analyze behavior in zebrafish (Danio rerio)
Julian T. Pittman et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Comparing behavioral responses across multiple assays of stress and anxiety in zebrafish (Danio rerio)
Ryan Y. Wong et al.
BEHAVIOUR (2012)
A larval zebrafish model of bipolar disorder as a screening platform for neuro-therapeutics
Lee David Ellis et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Behavioral genetics in larval zebrafish: Learning from the young
Marc Wolman et al.
DEVELOPMENTAL NEUROBIOLOGY (2012)
Behavioral screening for neuroactive drugs in zebrafish
Jason Rihel et al.
DEVELOPMENTAL NEUROBIOLOGY (2012)
Pharmaceuticals and Personal Care Products in the Environment: What Are the Big Questions?
Alistair B. A. Boxall et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2012)
Human Therapeutic Plasma Levels of the Selective Serotonin Reuptake Inhibitor (SSRI) Sertraline Decrease Serotonin Reuptake Transporter Binding and Shelter-Seeking Behavior in Adult Male Fathead Minnows
Theodore W. Valenti et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2012)
Endocrine disruption due to estrogens derived from humans predicted to be low in the majority of U.S. surface waters
Paul D. Anderson et al.
ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY (2012)
Organization of the Histaminergic System in Adult Zebrafish (Danio rerio) Brain: Neuron Number, Location, and Cotransmitters
Maria Sundvik et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2012)
DECREASED AGGRESSIVE AND LOCOMOTOR BEHAVIORS IN BETTA SPLENDENS AFTER EXPOSURE TO FLUOXETINE
Jess G. Kohlert et al.
PSYCHOLOGICAL REPORTS (2012)
SPECIES EXTRAPOLATION FOR THE 21ST CENTURY
Malin C. Celander et al.
ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY (2011)
Evidence-based pharmacological treatment of generalized anxiety disorder
David S. Baldwin et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
The serotonergic system in fish
Christina Lillesaar
JOURNAL OF CHEMICAL NEUROANATOMY (2011)
PHARMACEUTICALS AS NEUROENDOCRINE DISRUPTORS: LESSONS LEARNED FROM FISH ON PROZAC
Jan A. Mennigen et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2011)
Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis
David Baldwin et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Measuring anxiety in zebrafish: A critical review
Caio Maximino et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Identification and developmental expression of the full complement of Cytochrome P450 genes in Zebrafish
Jared V. Goldstone et al.
BMC GENOMICS (2010)
ADVERSE OUTCOME PATHWAYS: A CONCEPTUAL FRAMEWORK TO SUPPORT ECOTOXICOLOGY RESEARCH AND RISK ASSESSMENT
Gerald T. Ankley et al.
ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY (2010)
Pharmaceuticals in the Aquatic Environment: Steroids and Anti-Steroids as High Priorities for Research
Tamsin J. Runnalls et al.
HUMAN AND ECOLOGICAL RISK ASSESSMENT (2010)
Rapid behavior-based identification of neuroactive small molecules in the zebrafish
David Kokel et al.
NATURE CHEMICAL BIOLOGY (2010)
Measuring behavioral and endocrine responses to novelty stress in adult zebrafish
Jonathan Cachat et al.
NATURE PROTOCOLS (2010)
Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake Regulation
Jason Rihel et al.
SCIENCE (2010)
Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals
Jason P. Berninger et al.
TOXICOLOGY LETTERS (2010)
Environmental risk assessment for the serotonin re-uptake inhibitor fluoxetine: Case study using the European risk assessment framework
Ken D Oakes et al.
Integrated Environmental Assessment and Management (2010)
Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish
Rupert J. Egan et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
AQUATIC TOXICITY OF SERTRALINE TO PIMEPHALES PROMELAS AT ENVIRONMENTALLY RELEVANT SURFACE WATER pH
Theodore W. Valenti et al.
ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY (2009)
Ultrastructural analysis of the glutamatergic system in the outer plexiform layer of zebrafish retina
Jan Klooster et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2009)
The presence of pharmaceuticals in the environment due to human use - present knowledge and future challenges
Klaus Kuemmerer
JOURNAL OF ENVIRONMENTAL MANAGEMENT (2009)
Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety
Zachary Bencan et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Evolutionary conservation of human drug targets in organisms used for environmental risk assessments
Lina Gunnarsson et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2008)
Anxiogenic effects of cocaine withdrawal in zebrafish
Marcos A. Lopez-Patino et al.
PHYSIOLOGY & BEHAVIOR (2008)
Movement disorders and neurochemical changes in zebrafish larvae after bath exposure to fluoxetine (PROZAC)
Mark J. Airhart et al.
NEUROTOXICOLOGY AND TERATOLOGY (2007)
[3H] citalopram binding to serotonin transporter sited in Minnow brains
Georgianna G. Gould et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2007)
Emerging epilepsy models: insights from mice, flies, worms and fish
Scott C. Baraban
CURRENT OPINION IN NEUROLOGY (2007)
A practical demonstration in modelling diclofenac and propranolol river water concentrations using a GIS hydrology model in a rural UK catchment
A. C. Johnson et al.
ENVIRONMENTAL POLLUTION (2007)
Anxiolytic effects of nicotine in zebrafish
Edward D. Levin et al.
PHYSIOLOGY & BEHAVIOR (2007)
Modeling effects of mixtures of endocrine disrupting chemicals at the river catchment scale
John P. Sumpter et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2006)
Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine
MG Scordo et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2005)
Identification and functional evidence of GABAergic neurons in parts of the brain of adult zebrafish (Danio rerio)
YJ Kim et al.
NEUROSCIENCE LETTERS (2004)
Effects of chronic fluoxetine in animal models of anxiety and depression
SC Dulawa et al.
NEUROPSYCHOPHARMACOLOGY (2004)
A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish
DB Huggett et al.
HUMAN AND ECOLOGICAL RISK ASSESSMENT (2003)
Polymorphisms in the CYP 2D6 gene: Association with plasma concentrations of fluoxetine and paroxetine
C Charlier et al.
THERAPEUTIC DRUG MONITORING (2003)
Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine: Sources of variability and preliminary observations on relations with clinical response
G Jannuzzi et al.
THERAPEUTIC DRUG MONITORING (2002)
Pharmacodynamic activity of drugs and ecotoxicology - can the two be connected?
JP Seiler
TOXICOLOGY LETTERS (2002)
Concentrations of the enantiomers of fluoxetine and norfluoxetine after multiple doses of fluoxetine in cytochrome P4502D6 poor and extensive metabolizers
CB Eap et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Serum concentrations of fluoxetine in the clinical treatment setting
J Lundmark et al.
THERAPEUTIC DRUG MONITORING (2001)
Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats
YH Zhang et al.
BRAIN RESEARCH (2000)
Pharmacokinetics of selective serotonin reuptake inhibitors
C Hiemke et al.
PHARMACOLOGY & THERAPEUTICS (2000)
Catecholamine systems in the brain of vertebrates: new perspectives through a comparative approach
WJAJ Smeets et al.
BRAIN RESEARCH REVIEWS (2000)
分享论文
